Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
264 Results for "active component" in MCE Product Catalog:
Target:
Research Areas:
Neurological Disease Metabolic Disease Inflammation/Immunology Cancer
Trastuzumab deruxtecan (DS-8201a) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer .
Note: The product sizes indicate only the active ingredient of ADC. For information about the excipients in this product, please refer to the COA.
Plant Terpenoids Atractylodes macrocephala Koidz. Extract Sesquiterpenes Compositae/Asteraceae Extract Disease Research Fields Cancer
Infection Plant A.Sativam L. var.Viviparum Regel Extract Ketones, Aldehydes, Acids Liliaceae Extract Disease Research Fields
Natural Products Plant Aristolochiaceae Extract Asarum sieboldii Miq. Extract Disease Research Fields Inflammation/Immunology
Plant Tussilago farfara Linn. Extract Terpenoids Sesquiterpenes Compositae/Asteraceae Extract Disease Research Fields Inflammation/Immunology
Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06